NEWS

July 2021

  • July 21, 2021

    Shimadzu Releases Amyloid MS CL System for Measuring Candidate Substance Potentially Causing Alzheimer’s Disease
    System Requires Testing Only a Small Quantity of Blood, which Reduces Burden to Patients

  • July 7, 2021

    New Hydraulic Equipment Plant Completed to Meet Expanding Demand for Forklifts in China

June 2021

  • June 29, 2021

    Rapid, Robust LC-MS/MS Analysis of Biomarker Candidates that Show a Correlation to Increase Severity of COVID-19 Symptoms
    Release of Method Package for Modified Nucleoside Analysis System

  • June 25, 2021

    Updated the Corporate Governance page

  • June 25, 2021

    NOTICE OF RESOLUTIONS AT THE 158TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

  • June 24, 2021

    Switch to Renewable Energy at Major Domestic Locations
    Promoting the use of renewable energy for electricity use as declared in RE100

  • June 18, 2021

    Rakuten Medical and Shimadzu Corporation announce a joint development and commercialization agreement on a medical device to be used with the Illuminox™ platform

  • June 2, 2021

    Notice Regarding the Signing of Basic Agreement of Business Partnership between SHIMADZU and SHIONOGI for Wastewater Surveillance for Viruses in the Field of Infectious Diseases, Including Novel Coronavirus

May 2021

  • May 26, 2021

    Mass spectrometry technology contributed to the advancement of cancer immunotherapy
    Discovering a Biomarker for Predicting the Clinical Outcome of Cancer Patients treated with a New Combination Immunotherapy in a Phase I Clinical Trial Conducted by Providence Cancer Institute, USA

  • May 21, 2021

    NOTICE OF THE 158TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

  • May 12, 2021

    FY2020-2022 Medium-Term Management Plan(Version Updated Due to the COVID-19 Pandemic:Adjusted Upward)

  • May 12, 2021

    FY2020 Operating Results & Financial Position, Q&A session transcript(summary)

  • May 11, 2021

    Earnings Report for the fiscal year ended March 31, 2021

  • May 11, 2021

    Notice Regarding Dividends of surplus

  • May 11, 2021

    Fact Book 2021, DATABOOK

  • May 6, 2021

    Shimadzu Scientific Instruments to Collaborate on Anti-aging Research at Washington University School of Medicine

April 2021

  • April 22, 2021

    Shimadzu Wins Germany’s iF DESIGN AWARD 2021 for Three Products
    Mass Spectrometer, Mass Microscope, and Environmentally Friendly Packaging Box

  • April 16, 2021

    Digital Mobile X-ray System MobileDaRt series exceeded 6,000 units worldwide sales

  • April 13, 2021

    Shimadzu Mass Spectrometer Receives “Best of the Best Award” and Mass Microscope Receives the “Red Dot Award”!
    - Red Dot Design Award 2021 -

March 2021

  • March 24, 2021

    Shimadzu Joins the Global Environmental Initiative RE100
    Aiming to Source 100 % Renewable Electricity

  • March 22, 2021

    For the Fifth Consecutive Year, Shimadzu was Selected as a Nadeshiko Brand that Actively Empowers Women within the Company

  • March 4, 2021

    First Time Selected as “Health and Productivity Management” Brand and Fifth Consecutive Year Certified as a “White 500” Company with Outstanding Health and Productivity Management Practices

  • March 1, 2021

    Release of World’s First TOF-PET System Specialized for Head and Breast Examinations
    Scanning Brain Tumors, Epilepsy and Breast Cancers with Outstanding Accuracy and Even Supporting Alzheimer’s and Other Dementia Researches

February 2021

  • February 26, 2021

    Notice of Changes in Excecutive Members

  • February 22, 2021

    Release of the Novel Coronavirus Detection Kit for Wipe Tests
    Allows quick and easy detection of the novel coronavirus on touch screens, doorknobs, etc. for efficient health and safety management

  • February 22, 2021

    Shimadzu Introduces SPM-Nanoa Scanning Probe Microscope
    Provides High-Level Operability and High-Speed Processing, with Automated Optical Adjustments and Observation Conditions Settings

  • February 12, 2021

    3rd Quarter Results & Financial Position for the Fiscal Year Ended March 2021, Q&A session Transcript(summary)

  • February 9, 2021

    Improved Functionality Supports Working Remotely
    Shimadzu’s New AOC-30 Series Automatic Sample Injection System for Gas Chromatographs

  • February 5, 2021

    Earnings Report for the nine months ended December 31, 2020

  • February 5, 2021

    Notice regarding Revised Forecasts of the year-end Dividend

  • February 5, 2021

    DATABOOK

January 2021

  • January 28, 2021

    Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment

  • January 21, 2021

    Sales of Novel Coronavirus PCR Testing Reagent Kits outside Japan Exports Began

  • January 20, 2021

    Initiation of Contract Analysis Services for the Automotive Industry with Foxconn, an Affiliate of Hon Hai: Joint Operation of Allied Laboratories at 22 Locations in China

  • January 19, 2021

    Shimadzu signs a collaboration agreement with TOTAL, a major Energy player and two European universities.
    Toward the Development of an Innovative "Oxygenated compound analysis system" for Biofuel Research

  • January 13, 2021

    Growth Strategy for Analytical & Measuring Instruments Business

  • January 6, 2021

    Celebrating 60th Anniversary of Remote-controlled Fluoroscopy System

June 2021

April 2021

February 2021

January 2021

July 2021

June 2021

May 2021

April 2021

March 2021

February 2021

January 2021

June 2021

May 2021

March 2021

February 2021

January 2021